Unknown

Dataset Information

Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.


ABSTRACT:

Background

Despite the use of modern immunochemotherapy regimens, a significant proportion of diffuse large B-cell lymphoma (DLBCL) patients will relapse. We proposed absolute lymphocyte count/absolute monocyte count ratio (ALC/AMC ratio) as a new prognostic factor in relapsed or primary refractory DLBCL.

Methods

We retrospectively analyzed 163 patients who have been diagnosed with relapsed or primary refractory DLBCL. The overall survival (OS) and progression-free survival (PFS) were measured from the time of first relapse. The Cox proportional hazards model was used to evaluate ALC/AMC ratio as prognostic factors for OS and PFS.

Results

On univariate and multivariate analysis performed with factors included in the saaIPI, early relapse, prior exposure to rituximab a

SUBMITTER: Li YL 

PROVIDER: S-EPMC4033684 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature